ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis

Wang, Jiabin; Yan, Shi; Chen, Xiaoli; Wang, Aowen; Han, Zhibin; Liu, Binchao; Shen, Hong*哈尔滨医科大学; 1
TECHNOLOGY IN CANCER RESEARCH & TREATMENT2022-5-10DOI: 10.1177/15330338211035270
3被引6阅读
引用收藏
分享

摘要

Objective: Glioblastoma multiforme (GBM) is the most malignant primary brain tumor in adults. This study aimed to identify significant prognostic biomarkers related to GBM. Methods: We collected 3 GBM and 3 healthy human brain samples for transcriptome and proteomic sequencing analysis. Differentially expressed genes (DEGs) between GBM and control samples were identified using the edge R package in R. Functional enrichment analyses, prediction of long noncoding RNA target genes, and protein-protein interaction network analyses were performed. Subsequently, transcriptomic and proteomic association analyses, validation using The Cancer Genome Atlas (TCGA) database, and survival and prognostic analyses were conducted. Then the hub genes directly related to GBM were screened. Finally, the expression of key genes was verified by quantitative polymerase chain reaction (qPCR). Results: Totally, 1140 transcripts and 503 proteins were significantly up- or down-regulated. A total of 25 genes were upregulated and 62 were downregulated at both the transcriptome and proteome levels. Results from TCGA database showed that 84 of these 87 genes matched with transcriptome sequencing results. A Cox regression analysis suggested that Fibronectin 1(FN1) was a prognostic risk factor. The qPCR results showed that FN1 was significantly upregulated in GBM samples. Conclusions: FN1 may play a role in GBM progression through ECM-receptor interaction and PI3K-Akt signaling pathways. FN1 may be considered as a prognostic biomarkers related to GBM.

学科与关键词

关键词
glioblastomadifferentially expressed genesproteome levelThe Cancer Genome Atlas Databaseprognostic analysis
相关
加载中…
  • SLC12A5 as a novel potential biomarker of glioblastoma multiforme
    Chen, Jiakai; Wang, Handong*; Deng, Chulei; Fei, MaoxingMolecular Biology Reports, 2023, 50(5): 4285-4299.
  • Comprehensive Analysis of Expression and Prognostic Value of MS4As in Glioma
    Zeng, Yingying; Tan, Peixin; Ren, Chen; Gao, Lianxuan; Chen, Yulei; Hu, Shushu; Tang, Nan; Chen, Chen; Du, Shasha*Frontiers in Genetics, 2022, 13: 795844.被引 6
  • Identification of an IFN-β-associated gene signature for the prediction of overall survival among glioblastoma patients
    Cheng, Lijing; Yuan, Meiling; Li, Shu; Lian, Zhiying; Chen, Junjing; Lin, Weibiao; Zhang, Jianbo*; Zhong, Shupeng*Annals of Translational Medicine, 2021, 9(11): 925.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
发表日期
2022-05-10
卷期
第 21 卷
页码
15330338211035270
DOI
10.1177/15330338211035270
语言
ENGLISH
成果收录
SCIE
资助标注
[LH2019H082]

作者

  • W

    Wang, Jiabin (第一作者)

    1 · harbin med univ

  • Y

    Yan, Shi

    1 · harbin med univ

查看全部 7 位作者收起作者
  • C

    Chen, Xiaoli

    1 · harbin med univ

  • W

    Wang, Aowen

    1 · harbin med univ

  • H

    Han, Zhibin

    1 · harbin med univ

  • L

    Liu, Binchao

    1 · harbin med univ

  • S

    Shen, Hong (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417